Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs

Critical Care Medicine

Volumn 31, Issue 9, 2003, Pages 2339-2343

  Leather, H Alex ^a   Ver Eycken, Kirsten ^a   Segers, Patrick ^b   Herijgers, Paul ^a   Vandermeersch, Eugène ^a   Wouters, Patrick F ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Calcium sensitizers; Inotropic agents; Levosimendan; Pig; Pulmonary vasculature; Ventricular function

Indexed keywords

LEVOSIMENDAN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FLOW MEASUREMENT; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; HOSPITAL LABORATORY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PULSATILE FLOW; RIGHT CORONARY ARTERY; SWINE; SYSTEMIC VASCULAR RESISTANCE; THORAX;

ANIMALS; CARDIAC OUTPUT; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HYDRAZONES; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; OXYGEN CONSUMPTION; PULMONARY CIRCULATION; PYRIDAZINES; SENSITIVITY AND SPECIFICITY; SWINE; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, RIGHT;

EID: 0041639573     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000084844.95073.C0     Document Type: Article

References (28)

1. Follath F, Cleland JG, Just H: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 2002; 360:196-202
2. Pagel PS, Harkin CP, Hettrick DA, et al: Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Anesthesiology 1994; 81:974-987
3. Pagel PS, Hettrick DA, Warltier DC: Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. Basic Res Cardiol 1996; 91:296-307
4. Du Toit EF, Muller CA, McCarthy J, et al: Levosimendan: Effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther 1999; 290:505-514
5. Oldner A, Konrad D, Weitzberg E, et al: Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 2001; 29:2185-2193
6. Gavazzi A, Berzuini C, Campana C, et al: Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J Heart Lung Transplant 1997; 16:774-785
7. Pollesello P, Ovaska M, Kaivola J, et al: Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J Biol Chem 1994; 269:28584-28590
8. Yokoshiki H, Katsube Y, Sunagawa M, et al: Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide- sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 1997; 333:249-259
9. Kersten JR, Montgomery MW, Pagel PS, et al: Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000; 90:5-11
10. De Witt BJ, Ibrahim IN, Bayer E, et al: An analysis of responses to levosimendan in the pulmonary vascular bed of the cat. Anesth Analg 2002; 94:1427-1433
11. U.S. National Institutes of Health: Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23). Bethesda, MD, National Institutes of Health, 1996
12. Leeuwenburgh BPJ, Helbing WA, Steendijk P, et al: Biventricular systolic function in young lambs subject to chronic systemic right ventricular pressure overload. Am J Physiol 2001; 281:H2697-H2704
13. Baan J, van der Velde ET, de Bruin HG, et al: Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 1984; 70:812-823
14. Kono A, Maughan WL, Sunagawa K, et al: The use of left ventricular end-ejection pressure and peak pressure in the estimation of the end-systolic pressure-volume relationship. Circulation 1984; 70:1057-1065
15. Raff GL, Glantz SA: Volume loading slows left ventricular isovolumic relaxation rate. Evidence of load-dependent relaxation in the intact dog heart. Circ Res 1981; 48:813-824
16. Leather HA, Segers P, Berends N, et al: Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 2002; 30:2548-2552
17. Nozawa T, Yasumura Y, Futaki S, et al: Efficiency of energy transfer from pressure-volume area to external mechanical work increases with contractile state and decreases with afterload in the left ventricle of the anesthetized closed-chest dog. Circulation 1988; 77:1116-1124
18. Greyson C, Xu Y, Cohen J, et al: Right ventricular dysfunction persists following brief right ventricular pressure overload. Cardiovasc Res 1997; 34:281-288
19. McGough MF, Pagel PS, Lowe D, et al: Effects of levosimendan on left ventricular function: Correlation with plasma concentrations in conscious dogs. J Cardiothorac Vasc Anesth 1997; 11:49-53
20. Haikala H, Nissinen E, Etemadzadeh E, et al: Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995; 25:794-801
21. Lee JA, Allen DG: EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle. Circ Res 1993; 69:927-936
22. Haikala H, Kaheinen P, Levijoki J, et al: The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res 1997; 34:536-546
23. Piene H: Impedance matching between ventricle and load. Ann Biomed Eng 1984; 12:191-207
24. Piene H, Sund T: Flow and power output of right ventricle facing load with variable input impedance. Am J Physiol 1979; 237:H125-H130
25. Ukkonen H, Saraste M, Akkila J, et al: Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000; 68:522-531
26. Ukkonen H, Saraste M, Akkila J, et al: Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Ther 1997; 61:596-607
27. Lilleberg J, Nieminen MS, Akkila J, et al: Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998; 19:660-668
28. Kivikko M, Antila S, Eha J, et al: Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. J Clin Pharmacol 2002; 42:43-51